Genotype 3 infection in DAA era: Preliminary reports of a real life northern Italy network for viral hepatitisL. Pasulo, Massimo Colombo, Alessio Aghemo et al.|Digestive and Liver Disease|2016Cited by 0
Treatment of chronic hepatitis C in Lombardia: An analysis on the safety and efficacy of DAA therapy in 5457 patientsAlessio Aghemo, S. Fagiuoli, L. Pasulo et al.|Digestive and Liver Disease|2017Cited by 0
Impaired renal function but high sustained virological response (SVR) rates in hepatitis C virus (HCV) elderly treated with direct-acting antivirals (DAA): A report from the Lombardy NetworkRoberta D’Ambrosio, S. Fagiuoli, L. Pasulo et al.|Digestive and Liver Disease|2018Cited by 0
Excellent effectiveness of direct-acting antivirals for HCV treatment in patients with cirrhosis: Analysis of 3345 patients from the Lombardia NetworkElisabetta Degasperi, S. Fagiuoli, L. Pasulo et al.|Digestive and Liver Disease|2018Cited by 0
Evolution of HCV treatments with direct acting antivirals between 2014 and 2017 in 8637 HCV patients in a real world setting: A report from the Lombardia Network and Navigator Study GroupElisabetta Degasperi, S. Fagiuoli, Maria Grazia Rumi et al.|Digestive and Liver Disease|2018Cited by 0